LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-10 Cr | ₹8.01 Cr | ₹-2.49 Cr | ₹-13 Cr | ₹39 Cr |
What is the latest Consolidated Net Profit of LYKA LABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-10 Cr |
| Mar2025 | ₹8.01 Cr |
| Mar2024 | ₹-2.49 Cr |
| Mar2023 | ₹-13 Cr |
| Mar2022 | ₹39 Cr |
How is Consolidated Net Profit of LYKA LABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-10 Cr | Negative | |
| Mar2025 | ₹8.01 Cr | Positive | |
| Mar2024 | ₹-2.49 Cr | Negative | |
| Mar2023 | ₹-13 Cr | Negative | |
| Mar2022 | ₹39 Cr | - | |
Compare Consolidated Net Profit of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹304.1 Cr | 6.5% | 25.7% | -16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 6.5% |
25.7% |
-16.9% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses